Film actor Bipasha Basu has voiced serious safety concerns regarding her dietary supplements, sparking wide public conversation across digital platforms. On September 10, Basu uploaded a video to her Instagram Stories revealing what appeared to be small insects crawling inside a newly unsealed tub of Isopure protein powder. Alarmed by the discovery, the actress reached out for regulatory intervention by tagging Maharashtra Food and Drug Administration (FDA) Commissioner Tukaram Mundhe in her post. In response to the growing public attention, the global nutrition brand has stepped forward with an official explanation and course of action.
Company Initiates Authenticity and Quality Audit
Sumit Mathur, General Manager at Glanbia Performance Nutrition (GPN) India, confirmed that company representatives promptly reached out to Bipasha Basu after learning of the incident. A dedicated technical team from Isopure has initiated a thorough examination of the specific container in question. The primary objective of this review is to ascertain whether the unit is an authentic factory product or an imitation, alongside evaluating its overall production and packaging quality. The company underscored that consumer safety, product hygiene, and rigorous quality standards continue to remain non-negotiable operational priorities.
Advisory on Counterfeit Products and QR Verification
The nutrition manufacturer highlighted ongoing vigilance efforts taken in partnership with corporate officials to track and curb the circulation of counterfeit supplements in regional markets. Isopure has strongly advised wellness consumers to purchase fitness products exclusively through verified retail merchants or certified digital storefronts. Shoppers were also urged to verify product authenticity prior to consumption by scanning the designated QR authentication code placed directly on each pack. Basu's initial September 10 social media appeal, directed at FDA Commissioner Tukaram Mundhe, brought immediate scrutiny onto the supply chain integrity of packaged health foods.
Intensive Food Safety Inspections Underway in Maharashtra
This supplement controversy coincides with an expansive regulatory crackdown managed by the Maharashtra FDA to tighten food safety and hygienic adherence across the state. Official records indicate that between June and August 2026, the regulatory body collected an aggregate of 37,604 product samples. Out of those, 34,584 were food items, and laboratory analyses have been finalized for 32,604 samples to date. In an intensive 100-day inspection drive, enforcement teams surveyed nearly 12,000 food establishments, kitchens, and retail outlets, resulting in immediate license suspensions and formal compliance notices wherever regulatory standards were breached.
